Finance

Beta
Lists
INKT:NASDAQ
Mink Therapeutics Inc
$11.34
-4.47%
(-0.53) 1D
Jun 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INKT...
Open
$11.63
High
$11.70
Low
$11.04
Mkt. cap
56.49M
Avg. vol.
38.55K
Volume
21.52K
52-wk high
$76.00
52-wk low
$6.80
EPS
-$2.84
Beta
0.47
Shares outstanding
4.98M
No. of employees
15
Open
$11.63
High
$11.70
Low
$11.04
Mkt. cap
56.49M
Avg. vol.
38.55K
Volume
21.52K
52-wk high
$76.00
52-wk low
$6.80
EPS
-$2.84
Beta
0.47
Shares outstanding
4.98M
No. of employees
15
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to INKT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for INKT in the last 3 months.
Highest
Current $11.34
$35.00 (+208.64%)
Average
$35.00 (+208.64%)
Lowest
$35.00 (+208.64%)
News stories
From sources across the web
About Mink Therapeutics Inc
CEO-
Employees15
Founded2017
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.84M
1.14M
1.51M
1.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.85M
1.85M
1.76M
1.68M
Operating expense
3.69M
3.18M
2.71M
2.88M
Total operating expenses
3.69M
3.18M
2.71M
2.88M
Operating income
-3.69M
-3.18M
-2.71M
-2.88M
Other non operating income
-185.70K
240.73K
-7.87K
58.58K
EBT including unusual items
-4.24M
-2.89M
-2.60M
-2.74M
EBT excluding unusual items
-3.87M
-2.89M
-2.60M
-2.74M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
193.92K
-571.10K
-
Net income
-4.24M
-2.89M
-2.60M
-2.74M
Net profit margin
-
-
-
-
Earnings per share
-1.06
-0.65
-0.56
-0.57
Interest and investment income
348.00
55.15K
111.23K
-
Interest expense
-
-
-
80.83K
Net interest expenses
348.00
55.15K
111.23K
80.83K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.64M
-3.14M
-2.67M
-2.85M
Gain or loss from assets sale
167.10K
2.19K
509.00
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more